[1]陈军, 甘华葵, 孙毅. 西格列汀与瑞格列奈治疗初诊2型糖尿病老年患者的效果比较[J]. 中国药房, 2016, 27(26):3711-3712. [2]聂鑫, 王晓征, 余益本,等. 西格列汀治疗老年2型糖尿病患者的效果及对胰岛功能的影响[J]. 中国临床保健杂志, 2016, 19(1):50-53. [3]Zhang Kun, Ren Qiao Hua, Wu Tao, et al. Effect of Western glentin on dawn phenomenon in patients with type 2 diabetes mellitus [J]. Journal of practical medicine, 2016, 32 (8): 1320-1321. [4]Liu Chunjun, Yan Yue, Yang Deqing. Clinical efficacy of insulin gliptin phosphate combined with insulin glargine in the treatment of elderly type 2 diabetes: [J]. Journal of clinical medication, 2016, 14 (1): 51-53. [5]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中国糖尿病杂志, 2014, 30(8):447-498. [6]黄金华. 西格列汀联合二甲双胍治疗老年2型糖尿病疗效分析[J]. 中华老年多器官疾病杂志, 2017, 16(5):358-361. [7]Ren Zhen, Zhang Wei, Wang Xiaoguang. Efficacy evaluation of different DPP-4 inhibitors combined with acarbose in the treatment of elderly type 2 diabetes mellitus [J]. southwest defense medicine, 2017, 27 (3): 273-275. [8]樊实真, 杨俊朋, 张春玲,等. 胰岛素促泌剂与阿卡波糖治疗新诊断2型糖尿病的疗效及对胰升血糖素样肽-1的调节作用[J]. 中国糖尿病杂志, 2016, 24(4):348-351. [9]叶潇, 张倩, 曹瑛,等. 西格列汀与阿卡波糖治疗新诊断2型糖尿病患者的疗效比较[J]. 中国糖尿病杂志, 2012, 20(8):619-621. [10]Zhong Wen, Li you Kong, Zeng Jiao e, et al. The efficacy of sggletine combined with acarbose in the treatment of newly diagnosed type 2 diabetes in elderly [J]. Journal of practical medicine, 2015, 31 (4): 649-651. [11]黄汉伟, 黎健南, 蔡雪,等. DPP-4抑制剂对胰岛素治疗2型糖尿病患者血糖波动的影响[J]. 重庆医学, 2017, 46(17):2365-2368. [12]敬仁芝, 曹晓红. 磷酸西格列汀联合阿卡波糖对老年2型糖尿病患者血糖、血脂及GLUT4水平的影响[J]. 中国药房, 2017, 28(9):1204-1207. [13]Zhong Wen, Li you Kong, Zeng Jiao e, et al. The efficacy of sggletine combined with acarbose in the treatment of newly diagnosed type 2 diabetes in elderly [J]. Journal of practical medicine, 2015, 31 (4): 649-651. [14]黄汉伟, 黎健南, 蔡雪,等. DPP-4抑制剂对胰岛素治疗2型糖尿病患者血糖波动的影响[J]. 重庆医学, 2017, 46(17):2365-2368. [15]敬仁芝, 曹晓红. 磷酸西格列汀联合阿卡波糖对老年2型糖尿病患者血糖、血脂及GLUT4水平的影响[J]. 中国药房, 2017, 28(9):1204-1207.
|